Market Report: “Biosynthesis of Cannabinoids: Vanguard of The Bio Revolution”

Report highlights:

Renew Biopharma’s platform recognized by Raymond James to be among the top 10 leaders of the biosynthesis revolution.

“While Renew’s work is focused on creating novel molecules, its improved enzymes can also be used to increase the production of natural cannabinoids in any microbial biosynthesis chassis”

“Renew recently received a Notice of Allowance from the US PTO for its patent covering derivatives of the ORF2 enzyme, a critical catalyst for the production of CBG-A.”